3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
7
Stomach Neoplasms
3
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Adenocarcinoma
2
Sarcoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Metastatic Gastric Adenocarcinoma
1
Head and Neck Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Advanced Gastric or EGJ Cancer
1
Interventions
Radiosurgery
23
Temozolomide
14
Magnetic Resonance Spectroscopy
14
pembrolizumab
11
Bevacizumab
11
Nivolumab
10
Ipilimumab
8
Specimen Handling
6
Memantine
6
abemaciclib
5
Radiotherapy
5
Mental Status and Dementia Tests
5
Blood Specimen Collection
5
Radiation
4
entrectinib
3
Surveys and Questionnaires
3
Sodium Chloride
3
Saline Solution
3
Receptors, Interleukin-8B
3
Proton Therapy
3
Lomustine
3
trastuzumab deruxtecan
2
trametinib
2
pertuzumab
2
osimertinib
2
lenvatinib
2
fluciclovine F-18
2
contrast agent BR1
2
atezolizumab
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Ramucirumab
×
90 days
×
Clear all
No trials found.